Proprotein convertase subtilisin/kexin type 9 inhibitors in secondary prevention of vascular events in patients with stroke: Consensus document and practice guidance A. Gil-Núñez; J. Masjuan; J. Montaner; M. Castellanos; T. Segura; P. Cardona; J.I. Tembl; F. Purroy; J. Arenillas; E. Palacio;

Dyslipidemias and stroke prevention: Recommendations of the Study Group of Cerebrovascular Diseases of the Spanish Society of Neurology E.J. Palacio-Portilla; J. Roquer; S. Amaro; J.F. Arenillas; O. Ayo-Martín; M. Castellanos; M.M. Freijo; B. Fuentes; A. García-Pastor; M. Gomis; M. Gómez-Choco; E. López-Cancio; P. Martínez-Sánchez; A. Morales; M. Rodríguez-Yáñez; T. Segura; J. Serena; J. Vivancos-Mora; M.A. de Leciñana;

SEGUICTUS study: management and follow-up of patients with stroke in Spain F. Acebrón; R. Valverde;